Three things you need to know in the financial markets this morning from investment writer, Tony Cross.
Aquis Exchange [LON:AQX] has published its interim results this morning, covering the period to June 30th. Revenues jumped by 42% to almost £5 million, with the company moving into profit as a result. The market share of all European trading also grew from 3.56% to 4.51%. The venue has interesting ambitions which include the prohibiting of short selling, something which could well help attract more new issuers over time.
Waste management firm Biffa [LON:BIFF] has issued a trading update today. Business has remained slightly above the base case set out at the start of the pandemic, with August revenues having recovered to 90% and the company expects to cease is furlough scheme this month. On the basis consumption generates more waste, the company’s near term fortunes are tied to the shape of the economic recovery, Current expectations remain unchanged.
Synairgen [LON:SNG] has issued an IP update this morning. Following yesterday’s successful Phase II trial announcement in COPD patients, the company has submitted a patent application to cover treatment for this cohort. The note adds that whilst this is a positive development, the focus remains on use of the SNG001 therapy when treating COVID-19. Whether this is sufficient to offer shares another boost is something likely worth watching.
Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.